Gianluca Caridi Selected Research

NPHS2 protein

7/2013	Genetic screening in adolescents with steroid-resistant nephrotic syndrome.
6/2009	Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations.
1/2006	Rare functional variants of podocin (NPHS2) promoter in patients with nephrotic syndrome.
7/2005	Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes.
5/2005	NPHS2 (Podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms.
4/2004	Infantile steroid-resistant nephrotic syndrome associated with double homozygous mutations of podocin.
7/2003	Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood.
6/2003	Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
5/2003	Broadening the spectrum of diseases related to podocin mutations.
1/2003	Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gianluca Caridi Research Topics

Disease

28	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2021 - 12/2001
13	Proteinuria 01/2022 - 12/2001
10	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2021 - 12/2001
6	Kidney Diseases (Kidney Disease) 01/2020 - 12/2004
6	Chronic Kidney Failure (Chronic Renal Failure) 09/2019 - 12/2001
4	Fibrosis (Cirrhosis) 01/2016 - 08/2002
4	Renal Insufficiency (Renal Failure) 12/2004 - 01/2003
3	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2022 - 12/2002
3	Hyperuricemia 09/2019 - 12/2004
3	Hypercholesterolemia 03/2012 - 12/2002
2	Sclerosis 01/2022 - 12/2002
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2022 - 01/2018
2	Epilepsy (Aura) 01/2021 - 01/2014
2	Hyperlipidemias (Hyperlipidemia) 01/2019 - 02/2003
2	Infections 01/2018 - 06/2009
2	Dent Disease 01/2016 - 10/2009
2	Segmental glomerulosclerosis 07/2014 - 01/2006
2	Cysts 04/2012 - 08/2002
2	Juvenile gout 02/2009 - 12/2004
1	Bone Marrow Failure Disorders 01/2022
1	Autoimmune Lymphoproliferative Syndrome 01/2022
1	Immunoglobulin G4-Related Disease 01/2022
1	IGA Glomerulonephritis (IGA Nephropathy) 07/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Fatigue 01/2019
1	Cough 01/2018
1	Arthritis (Polyarthritis) 01/2018
1	Exanthema (Rash) 01/2018
1	Fever (Fevers) 01/2018
1	Nephrosis 01/2018
1	Lung Injury 01/2018
1	Hypoalbuminemia 09/2016
1	Lymphoma (Lymphomas) 04/2016
1	Nephrocalcinosis 01/2016
1	Hypercalcemia (Milk Alkali Syndrome) 01/2016
1	Hypercalciuria 01/2016
1	Nephrolithiasis 01/2016
1	Infantile Hypercalcemia 01/2016
1	diffuse Mesangial sclerosis 05/2014
1	Hydrocephalus (Hydrocephaly) 05/2013
1	Cystic Kidney Diseases (Cystic Kidney Disease) 05/2013
1	Congenital Abnormalities (Deformity) 01/2013
1	Urinary Tract Infections (Urinary Tract Infection) 04/2012
1	Chronic Renal Insufficiency 04/2012

Drug/Important Bio-Agent (IBA)

15	SteroidsIBA 11/2021 - 12/2001
12	NPHS2 proteinIBA 07/2013 - 12/2001
11	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
5	Rituximab (Mabthera)FDA Link 11/2021 - 11/2013
4	Calcineurin InhibitorsIBA 01/2020 - 02/2010
4	AlbuminsIBA 01/2019 - 08/2004
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2014 - 04/2004
3	AntibodiesIBA 01/2022 - 04/2016
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2021 - 01/2020
3	CreatinineIBA 09/2019 - 09/2009
3	Pharmaceutical PreparationsIBA 04/2016 - 01/2009
3	UromodulinIBA 04/2012 - 12/2004
3	nephrinIBA 03/2011 - 07/2005
2	GlucocorticoidsIBA 11/2021 - 05/2008
2	ofatumumab FDA Link 01/2020 - 01/2018
2	Messenger RNA (mRNA)IBA 07/2014 - 10/2006
2	Prednisone (Sone)FDA LinkGeneric 11/2013 - 01/2009
2	TRPC6 Cation ChannelIBA 07/2011 - 07/2011
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 03/2011 - 10/2006
2	Amino Acids FDA Link 10/2009 - 10/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2002 - 12/2001
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Collagen Type IV (Type IV Collagen)IBA 07/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Moxifloxacin (Avelox)FDA Link 01/2020
1	ReninIBA 12/2019
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	polyanionsIBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	Puromycin AminonucleosideIBA 01/2018
1	Fluconazole (Zonal)FDA LinkGeneric 01/2018
1	CytokinesIBA 01/2018
1	Monoclonal AntibodiesIBA 04/2016
1	VitaminsIBA 01/2016
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2016
1	Vitamin D3 24-HydroxylaseIBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	ProteomeIBA 01/2016
1	1,25-dihydroxyvitamin DIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 05/2014
1	Ligand-Gated Ion ChannelsIBA 01/2014
1	MorpholinosIBA 05/2013
1	Retroelements (Retrotransposon)IBA 01/2013
1	Biological ProductsIBA 04/2012

Therapy/Procedure

6	Therapeutics 01/2020 - 01/2006
2	Transplantation 03/2007 - 12/2001
2	Kidney Transplantation 06/2003 - 07/2002
2	Plasmapheresis 07/2002 - 12/2001
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022
1	Premedication 01/2018